Kay Delasalle

5.1k total citations
61 papers, 3.4k citations indexed

About

Kay Delasalle is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Kay Delasalle has authored 61 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Hematology, 41 papers in Oncology and 30 papers in Molecular Biology. Recurrent topics in Kay Delasalle's work include Multiple Myeloma Research and Treatments (48 papers), Cancer Treatment and Pharmacology (30 papers) and Protein Degradation and Inhibitors (19 papers). Kay Delasalle is often cited by papers focused on Multiple Myeloma Research and Treatments (48 papers), Cancer Treatment and Pharmacology (30 papers) and Protein Degradation and Inhibitors (19 papers). Kay Delasalle collaborates with scholars based in United States, China and Greece. Kay Delasalle's co-authors include Raymond Alexanian, Meletios Α. Dimopoulos, Donna Weber, Maria Gavino, Lia A. Moulopoulos, Bart Barlogie, Sergio Giralt, Michael Wang, D. Weber and Terry Smith and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Kay Delasalle

60 papers receiving 3.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kay Delasalle United States 31 2.6k 1.7k 1.6k 953 643 61 3.4k
Margaret Macro France 24 1.7k 0.6× 1.4k 0.8× 1.8k 1.1× 720 0.8× 1.4k 2.2× 83 3.6k
Rudolf Schlag Germany 16 973 0.4× 871 0.5× 1.0k 0.6× 808 0.8× 669 1.0× 60 2.3k
Catherine Payen France 16 2.4k 0.9× 1.4k 0.8× 1.2k 0.7× 325 0.3× 314 0.5× 25 3.0k
Marzia Varettoni Italy 25 1.3k 0.5× 721 0.4× 790 0.5× 1.7k 1.7× 1.2k 1.9× 98 2.8k
Rik Schots Belgium 15 1.1k 0.4× 570 0.3× 999 0.6× 446 0.5× 751 1.2× 37 2.0k
Michael J. Barnett Canada 30 1.8k 0.7× 474 0.3× 698 0.4× 1.0k 1.1× 712 1.1× 115 2.9k
R. Kuse Germany 26 1.4k 0.5× 518 0.3× 734 0.5× 703 0.7× 763 1.2× 78 2.4k
Paola Tacchetti Italy 25 2.4k 0.9× 1.5k 0.9× 1.6k 1.0× 309 0.3× 143 0.2× 87 2.8k
J M Bennett United States 22 2.0k 0.8× 951 0.6× 939 0.6× 1.8k 1.9× 1.2k 1.8× 39 4.0k
Thomas Moehler Germany 25 1.4k 0.5× 1.1k 0.6× 739 0.5× 281 0.3× 158 0.2× 69 2.1k

Countries citing papers authored by Kay Delasalle

Since Specialization
Citations

This map shows the geographic impact of Kay Delasalle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kay Delasalle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kay Delasalle more than expected).

Fields of papers citing papers by Kay Delasalle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kay Delasalle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kay Delasalle. The network helps show where Kay Delasalle may publish in the future.

Co-authorship network of co-authors of Kay Delasalle

This figure shows the co-authorship network connecting the top 25 collaborators of Kay Delasalle. A scholar is included among the top collaborators of Kay Delasalle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kay Delasalle. Kay Delasalle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cohen, Lorenzo, Ying Guo, Yuhong Zhou, et al.. (2014). Electroacupuncture for thalidomide/bortezomib-induced peripheral neuropathy in multiple myeloma: a feasibility study. Journal of Hematology & Oncology. 7(1). 41–41. 47 indexed citations
2.
Alexanian, Raymond, Kay Delasalle, Michael Wang, Sheeba K. Thomas, & Donna Weber. (2012). Curability of Multiple Myeloma. PubMed. 2012. 1–5. 19 indexed citations
3.
Fu, Weijun, Kay Delasalle, Jialei Wang, et al.. (2011). Bortezomib-Cyclophosphamide-Dexamethasone for Relapsing Multiple Myeloma. American Journal of Clinical Oncology. 35(6). 562–565. 10 indexed citations
4.
Wang, Haijun, Yi‐Ming Chen, Fanglin Li, et al.. (2011). Temporal and geographic variations of Waldenstrom macroglobulinemia incidence. Cancer. 118(15). 3793–3800. 75 indexed citations
5.
Wang, M, Kay Delasalle, Lei Feng, et al.. (2009). CR represents an early index of potential long survival in multiple myeloma. Bone Marrow Transplantation. 45(3). 498–504. 39 indexed citations
6.
Delasalle, Kay, Lühua Wang, Donna Weber, et al.. (2009). Curability of Multiple Myeloma.. Blood. 114(22). 3864–3864.
7.
Zhou, Yuhong, Haijun Wang, Yanxia Zhang, et al.. (2008). Incidence trends of mantle cell lymphoma in the United States between 1992 and 2004. Cancer. 113(4). 791–798. 184 indexed citations
8.
Moulopoulos, Lia A., Dimitra Gika, Αchilles Anagnostopoulos, et al.. (2005). Prognostic significance of magnetic resonance imaging of bone marrow in previously untreated patients with multiple myeloma. Annals of Oncology. 16(11). 1824–1828. 80 indexed citations
9.
Wang, Michael, Donna M. Weber, Kay Delasalle, & Raymond Alexanian. (2005). Thalidomide–dexamethasone as primary therapy for advanced multiple myeloma. American Journal of Hematology. 79(3). 194–197. 26 indexed citations
10.
Alexanian, Raymond, D. Weber, Kay Delasalle, et al.. (2004). Clinical outcomes with intensive therapy for patients with primary resistant multiple myeloma. Bone Marrow Transplantation. 34(3). 229–234. 23 indexed citations
11.
Liebross, Robert H., Chul S. Ha, James D. Cox, et al.. (1998). Solitary bone plasmacytoma: outcome and prognostic factors following radiotherapy. International Journal of Radiation Oncology*Biology*Physics. 41(5). 1063–1067. 117 indexed citations
12.
Giralt, Sergio, D. Weber, Meletios Α. Dimopoulos, et al.. (1997). Phase I trial of cyclosporine-induced autologous graft-versus-host disease in patients with multiple myeloma undergoing high-dose chemotherapy with autologous stem-cell rescue.. Journal of Clinical Oncology. 15(2). 667–673. 28 indexed citations
13.
Dimopoulos, Meletios Α., D. Weber, Kay Delasalle, Michael J. Keating, & Raymond Alexanian. (1995). Treatment of Waldenstrom's macroglobulinemia resistant to standard therapy with 2-chlorodeoxyadenosine: Identification of prognostic factors. Annals of Oncology. 6(1). 49–52. 57 indexed citations
14.
Dimopoulos, Meletios Α., Donna M. Weber, Jeane P. Hester, et al.. (1994). Intensive Sequential Therapy for VAD-Resistant Multiple Myeloma. Leukemia & lymphoma. 13(5-6). 479–484. 6 indexed citations
15.
Alexanian, R., Meletios Α. Dimopoulos, J. P. Hester, Kay Delasalle, & R. Champlin. (1994). Early myeloablative therapy for multiple myeloma. Blood. 84(12). 4278–4282. 94 indexed citations
16.
Dimopoulos, Meletios Α., H. Kantarjian, D. Weber, et al.. (1994). Primary therapy of Waldenström's macroglobulinemia with 2-chlorodeoxyadenosine.. Journal of Clinical Oncology. 12(12). 2694–2698. 95 indexed citations
17.
Dimopoulos, Meletios Α., Donna Weber, Kay Delasalle, & Raymond Alexanian. (1993). Combination therapy with interferon‐dexamethasone for newly diagnosed patients with multiple myeloma. Cancer. 72(9). 2589–2592. 16 indexed citations
18.
Dimopoulos, Meletios Α., Susan O’Brien, Hagop M. Kantarjian, et al.. (1993). Fludarabine therapy in Waldenström's macroglobulinemia. The American Journal of Medicine. 95(1). 49–52. 84 indexed citations
19.
Dimopoulos, Meletios Α., Kay Delasalle, Richard Champlin, & Raymond Alexanian. (1993). Cyclophosphamide and etoposide therapy with GM‐CSF for VAD‐resistant multiple myeloma. British Journal of Haematology. 83(2). 240–244. 28 indexed citations
20.
Dimopoulos, Meletios Α., Jeffrey Goldstein, Lillian M. Fuller, Kay Delasalle, & Raymond Alexanian. (1992). Curability of solitary bone plasmacytoma.. Journal of Clinical Oncology. 10(4). 587–590. 77 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Margaret Macro Breakdown of academic impact, for papers by Rudolf Schlag Breakdown of academic impact, for papers by Catherine Payen Breakdown of academic impact, for papers by Marzia Varettoni Breakdown of academic impact, for papers by Rik Schots Breakdown of academic impact, for papers by Michael J. Barnett Breakdown of academic impact, for papers by R. Kuse Breakdown of academic impact, for papers by Paola Tacchetti Breakdown of academic impact, for papers by J M Bennett Breakdown of academic impact, for papers by Thomas Moehler
Rankless by CCL
2026